KDCA, SK bioscience launch support programme to shield South Korea against future pandemic influenza… EP News Bureau May 26, 2025 This government-led initiative focuses on developing vaccines against avian influenza that are identified as high-risk candidates…
S Korea to buy 10 million doses of SK Bioscience’s COVID vaccine Reuters Mar 23, 2022 The South Korean company has since August conducted phase-III trials of its vaccine candidate, codenamed "GBP510," jointly…
Celltrion develops neutralising antibody cocktail to tackle COVID-19 variant spread EP News Bureau Feb 11, 2021 CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant…
